☆ 4.4 Editorial Material

Germline and somatic mutations in prostate cancer: focus on defective DNA repair, PARP inhibitors and immunotherapy

FUTURE ONCOLOGY (2020)

Journal

FUTURE ONCOLOGY

Volume 16, Issue 5, Pages 75-80

Publisher

FUTURE MEDICINE LTD

DOI: 10.2217/fon-2019-0745

Keywords

BRCA1; BRCA2; defective DNA repair; immunotherapy; PARP inhibitors; prostate cancer

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.